贵州医科大学学报2024,Vol.49Issue(1) :139-144.DOI:10.19367/j.cnki.2096-8388.2024.01.020

糖皮质激素不同给药方式对AECOPD患者临床疗效的影响

Clinical efficacy of varied administration of glucocorticoid in patients with AECOPD

龙宇 刘礼银 杨然 胡系伟
贵州医科大学学报2024,Vol.49Issue(1) :139-144.DOI:10.19367/j.cnki.2096-8388.2024.01.020

糖皮质激素不同给药方式对AECOPD患者临床疗效的影响

Clinical efficacy of varied administration of glucocorticoid in patients with AECOPD

龙宇 1刘礼银 2杨然 2胡系伟3
扫码查看

作者信息

  • 1. 贵州医科大学临床医学院,贵州贵阳 550004;铜仁市人民医院呼吸与危重症医学科,贵州铜仁 554300
  • 2. 贵州医科大学临床医学院,贵州贵阳 550004
  • 3. 贵州医科大学临床医学院,贵州贵阳 550004;贵州医科大学附属医院呼吸与危重症医学科,贵州贵阳 550004
  • 折叠

摘要

目的 探究糖皮质激素不同给药方式在慢性阻塞性肺疾病急性加重期(AECOPD)患者治疗中的临床疗效.方法 88例AECOPD患者随机均分为吸入组与静脉组,两组患者均给予抗感染、吸氧、祛痰、解痉平喘、舒张气道等对症支持治疗的基础上,静脉组患者静脉注射甲泼尼龙琥珀酸钠(40 mg/次、1次/d),吸入组患者雾化吸入布地奈德(2 mg/次、3次/d),两组均治疗7 d;比较两组患者治疗前后动脉血氧分压(PaO2)、动脉血二氧化碳分压(PaCO2)、第1秒用力呼气容积占预计值百分比(FEV1%)、第1秒用力呼气容积占用力肺活量的比值(FEV1/FVC)、自我评估测试(CAT)评分.结果 与治疗前相比,两组患者治疗后PaO2均升高、PaCO2均下降、FEV,%及FEV1/FVC均升高(P<0.05);两组患者CAT评分均较治疗前降低(P<0.05);两组间患者治疗疗效相当,但吸入组不良反应发生率低于静脉组(P<0.05).结论 糖皮质激素治疗AECOPD患者,无论何种给药方式,均可取得良好的治疗效果,但雾化吸入较全身应用不良反应少,安全性更高.

Abstract

Objective To investigate the clinical efficacy of varied glucocorticoid administration in patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD).Methods Eighty-eight AECOPD patients were randomized into inhalation and venous groups on even number.On the basic treatment of anti-infection,oxygen inhalation,expectorant,anti-spasmodic and anti-asthma,and diastolic airway,patients in the venous group received intravenous methylprednisolone sodium succinate(40 mg/time,1 time/d),while patients in the inhalation group inhaled budesonide(2 mg/time,3 times/d).Both groups were treated for 7 d.Comparing the results of both groups:arterial oxygen partial pressure(PaO2),arterial carbon dioxide partial pressure(PaCO2),the estimated ratio of forced expiratory volume in the first second(FEV1%),the ratio of forced expiratory volume in the first second(FEV1/FVC),self-assessment test(CAT).Results Compared with pretreatment,PaO2 increased,PaCO2 decreased,FEV1%and FEV1/FVC were elevated in both groups(P<0.05);CAT scores decreased in both groups(P<0.05);treatment efficacy was comparable between both groups,but the incidence of adverse effects in the inhalation group was lower than that of venous group(P<0.05).Conclusion Glucocorticoid treatment of AECOPD patients can achieve positive clinical efficacy regardless of the method of administration,but glucocorticoid inhalation shows fewer adverse reactions and higher safety than intravenous glucocorticoid application.

关键词

慢性阻塞性肺疾病/急性加重期/糖皮质激素/不同给药方式/肺功能/血气分析

Key words

chronic obstructive pulmonary disease/acute exacerbation/glucocorticoid/varied administration/pulmonary function/blood gas analysis

引用本文复制引用

基金项目

贵州省科技计划项目(黔科合支撑[2021]一般059)

出版年

2024
贵州医科大学学报
贵阳医学院

贵州医科大学学报

CSTPCD
影响因子:0.827
ISSN:2096-8388
参考文献量30
段落导航相关论文